BioGend Therapeutics Co., Ltd.
TPEX:6733
NT$ 36.60
NT$-0.85 (-2.27%)
NT$ 36.60
NT$-0.85 (-2.27%)
End-of-day quote: 05/13/2024

6733 - BioGend Therapeutics Stock Prediction 2025 - 2030

5 years of reliable BioGend Therapeutics stock forecast. The Wall Street analysts predict Outperform for 6733. See at a glance whether TPEX:6733 will rise in the future.

NT$0.00
Forecast 2023
NT$42.39
Forecast 2025
NT$66.31
Forecast 2030
Underperform
TopGraphs Quality Ranking
Forecast 2023
NT$0.00
Forecast 2025
NT$42.39
Forecast 2030
NT$66.31
TopGraphs Quality Ranking
Underperform

Company Info

P/E
0.00
Beta
0.62
Price-to-book Ratio
N/A
Market Cap
4.55B
TEV
3.90 B
Dividend
NT$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
NT$33.00
Country

BioGend Therapeutics Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

BioGend Therapeutics Stock Forecast 2023

NT$48.00

In the last five quarters, BioGend Therapeutics’s Price Target has risen from NT$33.00 to NT$33.00 - a 0% increase. 0 analysts predict that BioGend Therapeutics’s share price will increase in the coming year, reaching NT$48.00. This would represent an increase of 45.45%.

31.15%
31.15
Last update: 05/14/2024

Highest Price Target NT$48.00

Average Price Target NT$48.00

Lowest Price Target NT$48.00

BioGend Therapeutics Stock Forecast 2025

Stock Prediction for the Price of One BioGend Therapeutics Share in Jan 2025.

In Jan 2025 analysts predict a share price of NT$39.07. An increase of 6.74% compared to today's share price.

Stock Prediction for the Price of One BioGend Therapeutics Share in Feb 2025.

In Feb 2025 analysts predict a share price of NT$39.37. An increase of 7.56% compared to today's share price.

Stock Prediction for the Price of One BioGend Therapeutics Share in Mar 2025.

In Mar 2025 analysts predict a share price of NT$39.67. An increase of 8.39% compared to today's share price.

Stock Prediction for the Price of One BioGend Therapeutics Share in Apr 2025.

In Apr 2025 analysts predict a share price of NT$39.97. An increase of 9.21% compared to today's share price.

Stock Prediction for the Price of One BioGend Therapeutics Share in May 2025.

In May 2025 analysts predict a share price of NT$40.27. An increase of 10.04% compared to today's share price.

Stock Prediction for the Price of One BioGend Therapeutics Share in Jun 2025.

In Jun 2025 analysts predict a share price of NT$40.58. An increase of 10.87% compared to today's share price.

Stock Prediction for the Price of One BioGend Therapeutics Share in Jul 2025.

In Jul 2025 analysts predict a share price of NT$40.88. An increase of 11.69% compared to today's share price.

Stock Prediction for the Price of One BioGend Therapeutics Share in Aug 2025.

In Aug 2025 analysts predict a share price of NT$41.18. An increase of 12.52% compared to today's share price.

Stock Prediction for the Price of One BioGend Therapeutics Share in Sep 2025.

In Sep 2025 analysts predict a share price of NT$41.48. An increase of 13.34% compared to today's share price.

Stock Prediction for the Price of One BioGend Therapeutics Share in Oct 2025.

In Oct 2025 analysts predict a share price of NT$41.79. An increase of 14.17% compared to today's share price.

Stock Prediction for the Price of One BioGend Therapeutics Share in Nov 2025.

In Nov 2025 analysts predict a share price of NT$42.09. An increase of 15% compared to today's share price.

Stock Prediction for the Price of One BioGend Therapeutics Share in Dec 2025.

In Dec 2025 analysts predict a share price of NT$42.39. An increase of 15.82% compared to today's share price.

BioGend Therapeutics Stock Predictions 2030

BioGend Therapeutics Stock Predictions for Jan 2030.

In January 2030 analysts predict a stock price of NT$61.11. An increase of 66.96% compared to the previous month's estimate.

BioGend Therapeutics Stock Predictions for Feb 2030.

In February 2030 analysts predict a stock price of NT$61.58. An increase of 68.25% compared to the previous month's estimate.

BioGend Therapeutics Stock Predictions for Mar 2030.

In March 2030 analysts predict a stock price of NT$62.05. An increase of 69.54% compared to the previous month's estimate.

BioGend Therapeutics Stock Predictions for Apr 2030.

In April 2030 analysts predict a stock price of NT$62.52. An increase of 70.83% compared to the previous month's estimate.

BioGend Therapeutics Stock Predictions for May 2030.

In May 2030 analysts predict a stock price of NT$63.00. An increase of 72.12% compared to the previous month's estimate.

BioGend Therapeutics Stock Predictions for Jun 2030.

In June 2030 analysts predict a stock price of NT$63.47. An increase of 73.42% compared to the previous month's estimate.

BioGend Therapeutics Stock Predictions for Jul 2030.

In July 2030 analysts predict a stock price of NT$63.94. An increase of 74.71% compared to the previous month's estimate.

BioGend Therapeutics Stock Predictions for Aug 2030.

In August 2030 analysts predict a stock price of NT$64.42. An increase of 76% compared to the previous month's estimate.

BioGend Therapeutics Stock Predictions for Sep 2030.

In September 2030 analysts predict a stock price of NT$64.89. An increase of 77.29% compared to the previous month's estimate.

BioGend Therapeutics Stock Predictions for Oct 2030.

In October 2030 analysts predict a stock price of NT$65.36. An increase of 78.59% compared to the previous month's estimate.

BioGend Therapeutics Stock Predictions for Nov 2030.

In November 2030 analysts predict a stock price of NT$65.84. An increase of 79.88% compared to the previous month's estimate.

BioGend Therapeutics Stock Predictions for Dec 2030.

In December 2030 analysts predict a stock price of NT$66.31. An increase of 81.17% compared to the previous month's estimate.

P/E
0.00
Beta
0.62
Price-to-book Ratio
N/A
Market Cap
4.55B
TEV
3.90 B
Dividend
NT$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
NT$33.00
Country

BioGend Therapeutics Analyst Ratings Frequently Asked Questions

Who are the analysts watching BioGend Therapeutics Co., Ltd.?

The following analysts have recently covered BioGend Therapeutics:

Masterlink Securities Corp.
(This information refers to the last 90 days.)

Who are the sell-side analysts watching BioGend Therapeutics Co., Ltd.?

The following sell-side analysts have recently covered BioGend Therapeutics:

Huang, Xiaowei
(This information refers to the last 90 days.)